Answers are grounded in this paper and cite their sources.
Objectives: Endovascular thrombectomy is widely recognized as the standard treatment for acute ischemic stroke caused by large vessel occlusion. However, the efficacy and safety of intravenous thrombolysis before endovascular thrombectomy in acute ischemic stroke patients with tandem lesions remain a subject of ongoing debate. Tandem lesions are characterized by concurrent intracranial large vessel occlusion and extracranial internal carotid artery stenosis or occlusion. The dual pathology of tandem lesions complicates therapeutic strategies. Herein, a systemic review is conducted to assess the efficacy and safety of intravenous thrombolysis combined with endovascular thrombectomy versus direct endovascular thrombectomy alone in patients with tandem lesions. Methods: Relevant literature was searched in PubMed, Embase, and the Cochrane Library from their inception to May 1, 2024. Five observational studies involving 1445 patients were included. Primary outcomes included 3-month clinical outcomes, reperfusion success rate, incidence of asymptomatic cerebral hemorrhage, and mortality rate. Results: Compared with direct endovascular thrombectomy alone, intravenous thrombolysis plus endovascular thrombectomy significantly improved 3-month clinical outcomes (odds ratio [OR] = 1.51, 95% confidence interval [CI]: 1.16–1.95), elevated reperfusion success rate (OR = 1.60, 95% CI: 1.21–2.11), and reduced 3-month mortality (OR = 0.69, 95% CI: 0.52–0.93). However, no significant difference was observed in the incidence of asymptomatic cerebral hemorrhage (OR = 0.93, 95% CI: 0.66–1.31) between the two treatment modalities. Additionally, three studies compared the therapeutic efficacy of tenecteplase and alteplase, revealing no significant differences in 3-month clinical outcomes, reperfusion success rates, incidence of asymptomatic cerebral hemorrhage, and mortality between the two thrombolytic agents. Subgroup analyses suggested that the benefits of intravenous thrombolysis plus endovascular thrombectomy were consistent across different patient populations, including age, baseline stroke severity, and time-to-treatment intervals. Conclusion: Intravenous thrombolysis combined with endovascular thrombectomy significantly improves clinical outcomes and reduces mortality in acute ischemic stroke patients with tandem lesions, without increasing the risk of asymptomatic cerebral hemorrhage. However, the current evidence is primarily derived from observational studies, which may involve selection bias and confounding factors. Further randomized controlled trials are warranted to validate these results and to explore the impact of patient-specific and surgical factors on clinical outcomes. This study was conducted in accordance with the Preferred Reporting Items for Systematic Evaluation and Meta-Analysis (PRISMA) statement, and the study protocol was registered with PROSPERO (registration No. CRD42024570536).
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: